• News
  • Contact Us

Health Newsletter - Translational Research: Improving the Efficiency of Drug Development

News

July 26, 2011




The Health Sciences practice is pleased to present the latest edition of Health News, with the title article, "Translational Research: Improving the Efficiency of Drug Development from Bench to Bedside and Back Again."

The development of safe and effective new drugs is an exceedingly difficult, expensive, and time-consuming process. Despite thousands of pharmaceutical development companies working to get new drugs to market and the approximately $50 billion spent every year, only 23 new molecular entities (NMEs) per year (on average) have received marketing approval from the FDA during the last 10 years. Of most concern is that, while expenditures have increased steadily since the mid-1990s, the number of drugs reaching the market has declined to a relatively low plateau.

Download the latest issue of Health News (PDF) to read more about the issues, technical approaches, and Exponent's expertise regarding drug development.

All Exponent newsletters are accessible in our newsletter section of the website.